Recent Developments in Zantac Litigation: Key Updates for Affected Consumers
Washington — Thousands of lawsuits have been filed against the manufacturers of Zantac and its generic forms, alleging that the popular heartburn medication may cause cancer. The legal battles represent a significant chapter in pharmaceutical litigation, underscoring ongoing concerns regarding drug safety and consumer protection. The controversy began after the U.S. Food and Drug Administration (FDA) warned in 2019 that Zantac (ranitidine) might contain a probable human carcinogen called N-nitrosodimethylamine (NDMA). Following these findings, the FDA requested the removal of all ranitidine products from the market in April 2020, leading to widespread recall and discontinuation … Read more